Skip Navigation LinksHome > June 2014 - Volume 9 - Issue 6 > Discoidin Domain Receptor 2 Signaling Networks and Therapy i...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0000000000000164
Gene of the Month

Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer

Payne, Leo S. PhD; Huang, Paul H. PhD

Collapse Box


Discoidin domain receptor 2 (DDR2) is an atypical receptor tyrosine kinase that binds to and is activated by collagen in the extracellular matrix. Recent exon sequencing studies have identified DDR2 to be mutated with a 3% to 4% incidence in squamous cell cancers of the lung. This article summarizes the current state of knowledge of DDR2 biology and signaling in lung squamous cell cancer. It also explores the context-dependent role of this receptor as both an oncogene and a tumor suppressor in cancer cells. Promising therapeutic opportunities based on existing and novel targeted small molecule inhibitors against DDR2 may provide new strategies for treating lung squamous cell cancer patients.

Copyright © 2014 by the European Lung Cancer Conference and the International Association for the Study of Lung Cancer.


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Other Ways to Connect



Visit on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.